Capital World Investors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$771M Buy
1,977,121
+4,692
+0.2% +$1.98M 0.09% 173
2026
Q1
$933M Sell
1,972,429
-3,026,993
-61% -$1.52B 0.13% 149
2025
Q4
$2.33B Buy
4,999,422
+40,086
+0.8% +$18.6M 0.32% 75
2025
Q3
$2.11B Buy
4,959,336
+179,443
+4% +$69.6M 0.29% 88
2025
Q2
$1.83B Buy
4,779,893
+1,399,488
+41% +$504M 0.27% 89
2025
Q1
$1.17B Buy
3,380,405
+451,953
+15% +$145M 0.19% 119
2024
Q4
$879M Buy
2,928,452
+19,121
+0.7% +$6.68M 0.13% 153
2024
Q3
$1.18B Buy
2,909,331
+22,324
+0.8% +$8.17M 0.18% 125
2024
Q2
$928M Buy
2,887,007
+94,630
+3% +$30.7M 0.15% 140
2024
Q1
$931M Buy
2,792,377
+1,019,750
+58% +$312M 0.15% 139
2023
Q4
$480M Buy
1,772,627
+936,823
+112% +$232M 0.09% 202
2023
Q3
$206M Buy
+835,804
New +$229M 0.04% 268

Other funds holding HCA

Capital World Investors's HCA Position: Q2 2026 in Review

Capital World Investors increased its HCA Healthcare (HCA) stake by 0.24% in Q2 2026, buying an estimated $1.98M and bringing the position to 1,977,121 shares worth $771M. The position accounts for 0.09% of the portfolio, ranked #173.

Capital World Investors first reported a position in HCA in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.33B in Q4 2025. 1,337 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Capital World Investors held 1,977,121 shares of HCA Healthcare worth $771M as of Q2 2026.
  • Capital World Investors bought 4,692 HCA Healthcare shares in Q2 2026, an estimated $1.98M.
  • HCA Healthcare made up 0.09% of Capital World Investors's portfolio in Q2 2026, its #173 holding.
  • Capital World Investors first reported a position in HCA Healthcare in Q3 2023 and has held it in 12 quarters since.
  • Capital World Investors's HCA Healthcare position peaked at $2.33B in Q4 2025.
  • 1,337 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Capital World Investors's 13F filing for Q2 2026, filed 12 Aug 2026.